Carboplatin Dose Calculator
Calculate precise chemotherapy doses using the Calvert formula based on patient-specific parameters for optimal treatment outcomes.
Calculate Carboplatin Dose
Recommended Carboplatin Dose
Based on Calvert formula: Dose (mg) = AUC × (GFR + 25)
About Carboplatin Dosing
Carboplatin is a chemotherapy drug used to treat various cancers including ovarian, lung, and head/neck cancers.
- Dosing follows the Calvert formula: Dose = AUC × (GFR + 25)
- Typical target AUC values range from 4-7 depending on treatment protocol and patient factors
- GFR should be measured using radionuclide methods or estimated using Cockcroft-Gault formula
- Doses are typically administered every 3-4 weeks
- Renal function: Dose adjustment critical for patients with impaired kidney function
- Treatment history: Previous chemotherapy may require dose reduction
- Bone marrow reserve: Consider baseline blood counts
- Concurrent medications: Some drugs may interact with carboplatin
- Monitor complete blood counts before each cycle
- Assess renal function periodically during treatment
- Watch for signs of hypersensitivity reactions
- Evaluate for ototoxicity and neurotoxicity with prolonged use
Understanding Carboplatin Dosing
Carboplatin dosing is more complex than many chemotherapy agents due to its dependence on renal function. The Calvert formula revolutionized carboplatin dosing by accounting for glomerular filtration rate (GFR).
Why GFR Matters
Unlike other chemotherapy drugs, carboplatin is primarily eliminated through the kidneys. Patients with impaired renal function will have slower clearance of the drug, leading to higher systemic exposure and increased risk of toxicity if doses aren’t adjusted.
Target AUC Selection
The target AUC (Area Under the Curve) determines treatment intensity:
- AUC 4-5: For palliative treatment or heavily pretreated patients
- AUC 6: Standard for most curative regimens
- AUC 7+: For fit patients in aggressive protocols
Important Disclaimer
This calculator provides estimates only. Actual dosing decisions should be made by qualified oncology professionals considering the complete clinical picture. Always verify GFR measurements and consider individual patient factors before administration.